1,2-dipalmitoylphosphatidylcholine and HIV Infections

1,2-dipalmitoylphosphatidylcholine has been researched along with HIV Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrieux, K; Bauduin, L; Bourgaux, C; Brisset, F; Caron, J; Chacun, H; Clayette, P; Couvreur, P; Degrouard, J; Dereuddre-Bosquet, N; Desmaële, D; Garcia-Argote, S; Gueutin, C; Lalanne, M; Paci, A; Rousseau, B; Skanji, R; Vassal, G	1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and HIV Infections

Article	Year
A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary. International journal of pharmaceutics, 2011, Jul-29, Volume: 414, Issue:1-2 Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Oral; Animals; Anti-HIV Agents; Didanosine; Drug Carriers; Drug Compounding; Drug Delivery Systems; Freeze Drying; HIV; HIV Infections; Humans; Leukocytes, Mononuclear; Liposomes; Nanostructures; Particle Size; Prodrugs; Rats; Rats, Wistar; Time Factors	2011

Article

Year

A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary.

International journal of pharmaceutics, 2011, Jul-29, Volume: 414, Issue:1-2

Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Oral; Animals; Anti-HIV Agents; Didanosine; Drug Carriers; Drug Compounding; Drug Delivery Systems; Freeze Drying; HIV; HIV Infections; Humans; Leukocytes, Mononuclear; Liposomes; Nanostructures; Particle Size; Prodrugs; Rats; Rats, Wistar; Time Factors

2011